Skip to main content
. 2013 Oct 29;43(5):227–232. doi: 10.5051/jpis.2013.43.5.227

Figure 3.

Figure 3

A box plot showing the salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin (sRANKL/OPG) ratio. The results of this study indicated that the salivary sRANKL/OPG ratio differed significantly between the two groups (P=0.001).